{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:30:25Z","timestamp":1790605825477,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40121-025-01181-8","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:22:31Z","timestamp":1751952151000},"page":"1577-1597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and Canada"],"prefix":"10.1007","volume":"14","author":[{"given":"Todd","family":"Wolynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayali","family":"Nerurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Galarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helay","family":"Hassas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Upegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corwin A.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Entenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Jones Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liga","family":"Bennetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen P.","family":"Neary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"1181_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9202-7_1","volume":"1969","author":"S Hollingshead","year":"2019","unstructured":"Hollingshead S, Tang CM. An overview of Neisseria meningitidis. Methods Mol Biol. 2019;1969:1\u201316.","journal-title":"Methods Mol Biol"},{"key":"1181_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41579-019-0282-6","volume":"18","author":"DA Caugant","year":"2020","unstructured":"Caugant DA, Brynildsrud OB. Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis. Nat Rev Microbiol. 2020;18:84\u201396.","journal-title":"Nat Rev Microbiol"},{"key":"1181_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","volume":"81","author":"SR Parikh","year":"2020","unstructured":"Parikh SR, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81:483\u201398.","journal-title":"J Infect"},{"key":"1181_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103571","volume":"134","author":"A Purmohamad","year":"2019","unstructured":"Purmohamad A, Abasi E, Azimi T, Hosseini S, Safari H, Nasiri MJ, et al. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: a systematic review and meta-analysis. Microb Pathog. 2019;134: 103571.","journal-title":"Microb Pathog"},{"key":"1181_CR5","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.010409","volume":"9","author":"ME Peterson","year":"2019","unstructured":"Peterson ME, Li Y, Bita A, Moureau A, Nair H, Kyaw MH, et al. Meningococcal serogroups and surveillance: a systematic review and survey. J Glob Health. 2019;9: 010409.","journal-title":"J Glob Health"},{"key":"1181_CR6","unstructured":"US Centers for Disease Control and Prevention. Enhanced Meningococcal Disease Surveillance Report, 2022 [Internet]. 2024. Available from: https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2022-508.pdf. Accessed 25 Feb 2025."},{"key":"1181_CR7","unstructured":"Public Health Agency of Canada. Invasive meningococcal disease: For health professionals [Internet]. Government of Canada; 2024. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/invasive-meningococcal\/health-professionals.html. Accessed 25 Feb 2025."},{"key":"1181_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jinf.2022.10.022","volume":"85","author":"EJ Asturias","year":"2022","unstructured":"Asturias EJ, Bai X, Bettinger JA, Borrow R, Castillo DN, Caugant DA, et al. Meningococcal disease in North America: Updates from the Global Meningococcal Initiative. J Infect. 2022;85:611\u201322.","journal-title":"J Infect"},{"key":"1181_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2022.03.032","volume":"119","author":"H Dubey","year":"2022","unstructured":"Dubey H, Oster P, Fazeli MS, Guedes S, Serafini P, Leung L, et al. Risk factors for contracting invasive meningococcal disease and related mortality: a systematic literature review and meta-analysis. Int J Infect Dis. 2022;119:1\u20139.","journal-title":"Int J Infect Dis"},{"key":"1181_CR10","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3201\/eid1206.051297","volume":"12","author":"J MacLennan","year":"2006","unstructured":"MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, et al. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis. 2006;12:950\u20137.","journal-title":"Emerg Infect Dis"},{"key":"1181_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","volume":"10","author":"H Christensen","year":"2010","unstructured":"Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:853\u201361.","journal-title":"Lancet Infect Dis"},{"key":"1181_CR12","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00431-020-03658-9","volume":"179","author":"P Spyromitrou-Xioufi","year":"2020","unstructured":"Spyromitrou-Xioufi P, Tsirigotaki M, Ladomenou F. Risk factors for meningococcal disease in children and adolescents: a systematic review and META-analysis. Eur J Pediatr. 2020;179:1017\u201327.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1181_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s41999-024-00969-0","volume":"15","author":"C Weil-Olivier","year":"2024","unstructured":"Weil-Olivier C, Taha MK, Leng S, Dinleyici EC, Bonanni P, Moya E, Leischker A, Yezli S. Invasive meningococcal disease in older adults: current perspectives and call for action. Eur Geriatr Med. 2024;15(3):729\u201341.","journal-title":"Eur Geriatr Med"},{"key":"1181_CR14","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.vaccine.2019.04.020","volume":"37","author":"B Wang","year":"2019","unstructured":"Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37:2768\u201382.","journal-title":"Vaccine"},{"key":"1181_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40121-018-0213-2","volume":"7","author":"KJ Olbrich","year":"2018","unstructured":"Olbrich KJ, M\u00fcller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7:421\u201338.","journal-title":"Infect Dis Ther"},{"key":"1181_CR16","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1186\/s12889-022-13342-2","volume":"22","author":"J Shen","year":"2022","unstructured":"Shen J, Begum N, Ruiz-Garcia Y, Martinon-Torres F, Bekkat-Berkani R, Meszaros K. Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review. BMC Public Health. 2022;22:1078.","journal-title":"BMC Public Health"},{"key":"1181_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/INF.0000000000000282","volume":"33","author":"C Stein-Zamir","year":"2014","unstructured":"Stein-Zamir C, Shoob H, Sokolov I, Kunbar A, Abramson N, Zimmerman D. The clinical features and long-term sequelae of invasive meningococcal disease in children. Pediatr Infect Dis J. 2014;33:777\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"1181_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12879-022-07129-4","volume":"22","author":"SS Voss","year":"2022","unstructured":"Voss SS, Nielsen J, Valentiner-Branth P. Risk of sequelae after invasive meningococcal disease. BMC Infect Dis. 2022;22:148.","journal-title":"BMC Infect Dis"},{"key":"1181_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1586\/eri.13.42","volume":"11","author":"A Vyse","year":"2013","unstructured":"Vyse A, Anonychuk A, J\u00e4kel A, Wieffer H, Nadel S. The burden and impact of severe and long-term sequelae of meningococcal disease. Expert Rev Anti Infect Ther. 2013;11:597\u2013604.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1181_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/jpids\/piv065","volume":"5","author":"L Strifler","year":"2016","unstructured":"Strifler L, Morris SK, Dang V, Tu HAT, Minhas RS, Jamieson FB, et al. The health burden of invasive meningococcal disease: a systematic review. J Pediatric Infect Dis Soc. 2016;5:417\u201330.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"1181_CR21","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/healthcare12111075","volume":"12","author":"M McMillan","year":"2024","unstructured":"McMillan M, McDonough J, Angliss M, Buttery J, Saunders L, Mathew SM, et al. Exploring the health-related quality of life and the lived experience of adolescents following invasive meningococcal disease. Healthcare. 2024;12:1075.","journal-title":"Healthcare"},{"key":"1181_CR22","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/INF.0b013e3182706b89","volume":"32","author":"JA Bettinger","year":"2013","unstructured":"Bettinger JA, Scheifele DW, Le Saux N, Halperin SA, Vaudry W, Tsang R. The disease burden of invasive meningococcal serogroup B disease in Canada. Pediatric Infect Dis J. 2013;32:e20\u20135.","journal-title":"Pediatric Infect Dis J"},{"key":"1181_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4161\/hv.7.4.14434","volume":"7","author":"KL Davis","year":"2011","unstructured":"Davis KL, Misurski D, Miller J, Karve S. Cost impact of complications in meningococcal disease: Evidence from a United States managed care population. Hum Vaccine. 2011;7:458\u201365.","journal-title":"Hum Vaccine"},{"key":"1181_CR24","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1086\/520303","volume":"26","author":"L Erickson","year":"1998","unstructured":"Erickson L, De Wals P. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990\u20131994. Clin Infect Dis. 1998;26:1159\u201364.","journal-title":"Clin Infect Dis"},{"key":"1181_CR25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/322587","volume":"33","author":"LJ Erickson","year":"2001","unstructured":"Erickson LJ, De Wals P, McMahon J, Heim S. Complications of meningococcal disease in college students. Clin Infect Dis. 2001;33:737\u20139.","journal-title":"Clin Infect Dis"},{"key":"1181_CR26","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s40121-024-01060-8","volume":"13","author":"O Herrera-Restrepo","year":"2024","unstructured":"Herrera-Restrepo O, Afroz N, Cabrera ES, Reaney M, Sowell FG, Kumar R, et al. Life after invasive meningococcal disease: insights from survivors and their caregivers. Infect Dis Ther. 2024;13:2563\u201379.","journal-title":"Infect Dis Ther"},{"key":"1181_CR27","doi-asserted-by":"publisher","first-page":"2436039","DOI":"10.1080\/21645515.2024.2436039","volume":"20","author":"O Herrera-Restrepo","year":"2024","unstructured":"Herrera-Restrepo O, Kwiatkowska M, Huse S, Kocaata Z, Ganz ML. Retrospective analysis of health and economic burden among commercially-insured individuals diagnosed with invasive meningococcal disease in the United States. Hum Vaccin Immunother. 2024;20:2436039.","journal-title":"Hum Vaccin Immunother"},{"key":"1181_CR28","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1016\/j.ehrm.2011.08.001","volume":"2","author":"S Karve","year":"2011","unstructured":"Karve S, Misurski D, Miller J, Davis KL. Costs of sequelae associated with invasive meningococcal disease: findings from a US managed care population. Health Outcomes Res Med. 2011;2:e215\u201326.","journal-title":"Health Outcomes Res Med"},{"key":"1181_CR29","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1155\/2009\/871071","volume":"20","author":"N Le Saux","year":"2009","unstructured":"Le Saux N, Bettinger JA, Wootton S, Halperin SA, Vaudry W, Scheifele DW, et al. Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection. Can J Infect Dis Med Microbiol. 2009;20:e130-134.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"1181_CR30","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s40121-024-01026-w","volume":"13","author":"GS Marshall","year":"2024","unstructured":"Marshall GS, McCormick ZL, Johns JS, Verduzco-Gutierrez M, Herrera-Restrepo O, Harrison LH. Understanding the sequelae of invasive meningococcal disease in the United States. Infect Dis Ther. 2024;13:2213\u201320.","journal-title":"Infect Dis Ther"},{"key":"1181_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1524-4733.2006.00113.x","volume":"9","author":"JA O\u2019Brien","year":"2006","unstructured":"O\u2019Brien JA, Caro JJ, Getsios D. Managing meningococcal disease in the United States: hospital case characteristics and costs by age. Value in Health. 2006;9:236\u201343.","journal-title":"Value in Health"},{"key":"1181_CR32","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1093\/cid\/civ028","volume":"60","author":"M Sadarangani","year":"2015","unstructured":"Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, et al. Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study. Clin Infect Dis. 2015;60:e27-35.","journal-title":"Clin Infect Dis"},{"key":"1181_CR33","unstructured":"Commission de la Sant\u00e9 et s\u00e9curit\u00e9 du travail. R\u00e8glement annot\u00e9 sur le bar\u00e8me des dommages corporels [in French]. Montreal, Canada; 1987."},{"key":"1181_CR34","unstructured":"Marso A. Written-only testimony in opposition to House Bill 2498, Kansas Legislature [Internet]. 2022 [cited 2025 Mar 26]. Available from: https:\/\/kslegislature.gov\/li_2022\/b2021_22\/committees\/ctte_h_hhs_1\/documents\/testimony\/20220221_57.pdf."},{"key":"1181_CR35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0895-4356(02)00448-1","volume":"55","author":"R Oostenbrink","year":"2002","unstructured":"Oostenbrink R, Moll HA, Essink-Bot M-L. The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison. J Clin Epidemiol. 2002;55:791\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1181_CR36","unstructured":"US Centers for Disease Control and Prevention. Meningococcal Disease Surveillance and Trends [Internet]. 2024 [cited 2025 Mar 3]. Available from: https:\/\/www.cdc.gov\/meningococcal\/php\/surveillance\/index.html#:~:text=Disease%20trends%20since%202021,disease%20cases%20reported%20since%202014. Accessed 3 Mar 2025."},{"key":"1181_CR37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/21645515.2018.1528831","volume":"15","author":"C Burman","year":"2019","unstructured":"Burman C, Serra L, Nuttens C, Presa J, Balmer P, York L. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccin Immunother. 2019;15:459\u201369.","journal-title":"Hum Vaccin Immunother"},{"key":"1181_CR38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/00006454-200010000-00009","volume":"19","author":"M Baker","year":"2000","unstructured":"Baker M, McNicholas A, Garrett N, Jones N, Stewart J, Koberstein V, et al. Household crowding a major risk factor for epidemic meningococcal disease in Auckland children. Pediatr Infect Dis. 2000;19:983\u201390.","journal-title":"Pediatr Infect Dis"},{"key":"1181_CR39","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1093\/cid\/ciaa1733","volume":"73","author":"M McMillan","year":"2021","unstructured":"McMillan M, Chandrakumar A, Wang HLR, Clarke M, Sullivan TR, Andrews RM, et al. Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: a systematic review and meta-analysis. Clin Infect Dis. 2021;73:e609\u201319.","journal-title":"Clin Infect Dis"},{"key":"1181_CR40","volume":"41","author":"L Helena De Oliveira","year":"2017","unstructured":"Helena De Oliveira L, Jauregui B, Carvalho AF, Giglio N. Impact and effectiveness of meningococcal vaccines: a review. Rev Panam Salud Publica. 2017;41: e158.","journal-title":"Rev Panam Salud Publica"},{"key":"1181_CR41","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jamapediatrics.2020.1990","volume":"174","author":"S Mbaeyi","year":"2020","unstructured":"Mbaeyi S, Pondo T, Blain A, Yankey D, Potts C, Cohn A, et al. Incidence of meningococcal disease before and after implementation of quadrivalent meningococcal conjugate vaccine in the United States. JAMA Pediatr. 2020;174:843\u201351.","journal-title":"JAMA Pediatr"},{"key":"1181_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-024-00666-2","author":"S Schillie","year":"2025","unstructured":"Schillie S, McNamara LA. Meningococcal vaccination in the United States: past, present, and future. Pediatr Drugs [Internet]. 2025. https:\/\/doi.org\/10.1007\/s40272-024-00666-2.","journal-title":"Pediatr Drugs [Internet]"},{"key":"1181_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","volume":"69","author":"SA Mbaeyi","year":"2020","unstructured":"Mbaeyi SA, Bozio CH, Duffy J, Rubin LG, Hariri S, Stephens DS, et al. Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020. MMWR Recomm Rep. 2020;69:1\u201341.","journal-title":"MMWR Recomm Rep"},{"key":"1181_CR44","doi-asserted-by":"crossref","unstructured":"Schillie S. New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, October 2024. MMWR Morb Mortal Wkly Rep [Internet]. 2024 [cited 2025 Mar 3];73. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/73\/wr\/mm7349a3.htm. Accessed 3 Mar 2025.","DOI":"10.15585\/mmwr.mm7349a3"},{"key":"1181_CR45","unstructured":"Public Health Agency of Canada. Recommended immunization schedules: Canadian Immunization Guide [Internet]. 2024 [cited 2025 Feb 26]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-1-key-immunization-information\/page-13-recommended-immunization-schedules.html. Accessed 26 Feb 2025."},{"key":"1181_CR46","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.43551","volume":"7","author":"T Shin","year":"2024","unstructured":"Shin T, Wells CR, Shoukat A, Potter-Schwartz L, Langevin E, Langley JM, et al. Quadrivalent conjugate vaccine and invasive meningococcal disease in US adolescents and young adults. JAMA Netw Open. 2024;7: e2443551.","journal-title":"JAMA Netw Open"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01181-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-025-01181-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01181-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:22:26Z","timestamp":1757208146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-025-01181-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1181"],"URL":"https:\/\/doi.org\/10.1007\/s40121-025-01181-8","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Rachel Dawson,, David P. Greenberg, Helay Hassas, Heather Entenmann, and Maureen P. Neary are employees of Sanofi Vaccines US and Angie Upegui, and Corwin A. Robertson are employees of Sanofi Vaccines Global and may hold shares and\/or stock options in the company. Katherine Galarza is a former employee of Sanofi Vaccines US. Sayali Nerurkar, Evan Jones Mann, and Liga Bennetts are employees of Amaris Consulting, which received professional fees from Sanofi for the study. Todd Wolynn has received consulting fees from Moderna, Pfizer, Merck, and Seqirus, payment or honoraria for lectures, presentations, speakers, bureaus, manuscript writing, or educational events from Moderna, and support for attending meetings and\/or travel from Moderna, Sanofi, and Seqirus. John B. Grimes or his corporation Cemblem, LLC have received grants or contracts and consulting fees from GSK and Convatec, payment or honoraria for lectures, presentations, speakers, bureaus, manuscript writing, or educational events from Sanofi and IQVIA, and support for attending meetings and\/or travel from GSK. He has participated in an advisory board for GSK and has a leadership or fiduciary role in the Confederation of Meningitis Organizations (Board Member) and Shots 4 Meningitis (Executive Director). Neither Todd Wolynn or John B. Grimes received compensation from Sanofi for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}